Clinical Trials Browser

Recruiting × INDUSTRY × folfirinox × Clear all

NCT05458219 2025-11-10

A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Locally Advanced Unresectable or Metastatic Solid Tumors

NCT05482893 2025-11-04

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

Phase 1/2 Recruiting

Gastrointestinal

Biliary Tract Neoplasms